Divergent Driver Mutation Frequencies and an Exploratory Prognostic Genomic Score in Colorectal Cancer: A Cohort Study from Kazakhstan

Colorectal cancer (CRC) exhibits substantial genomic heterogeneity across populations, yet patients from Kazakhstan remain markedly underrepresented in large-scale genomic studies. Here, we characterized the somatic mutational landscape of CRC in a cohort from Kazakhstan using targeted next-generation sequencing (NGS) and compared the observed genomic profile with data from the American Association for Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange (GENIE) database. Tumor samples from 32 patients with CRC were profiled using the TruSight Oncology 500 (TSO500) assay, and the mutation frequencies and patterns of co-occurring alterations were compared with those in a GENIE reference cohort of 770 CRC cases. The most frequently altered genes in the Kazakhstan cohort were TP53 (53%), APC (50%), and KRAS (44%). Comparative analysis identified differences in mutation frequencies between the analyzed cohorts, including a higher frequency of GNAS alterations (19%) and a lower frequency of APC alterations in the Kazakhstan cohort compared with the GENIE reference cohort. Co-occurrence analysis revealed recurrent combinations of driver alterations, including concurrent TP53 and KRAS mutations. To explore the clinical relevance of the genomic profile, a cohort-derived 11-gene cumulative mutation score was evaluated in survival analysis. A higher score was associated with shorter progression-free survival (PFS) in univariable Cox regression (HR, 1.23; 95% CI, 1.02–1.50; p = 0.034), but this association was not retained after adjustment for age, sex, and pathological stage (HR, 1.07; 95% CI, 0.84–1.36; p = 0.587). The score showed a moderate positive correlation with tumor mutational burden (TMB), which persisted after exclusion of the hypermutated microsatellite instability-high (MSI-H) case. However, the association between TMB and PFS was not retained after exclusion of this case. Bootstrap validation of the full multivariable Cox model indicated potential overfitting, with the optimism-corrected C-index decreasing from 0.732 to 0.650. These findings provide an initial molecular characterization of CRC in a cohort of patients from Kazakhstan and identify differences in selected somatic mutation frequencies compared with an international reference dataset. However, the limited sample size and differences in clinical and technical characteristics between cohorts preclude conclusions regarding population-specific genomic features. The prognostic findings remain exploratory and require validation in larger, independent cohorts. These results highlight the importance of expanding genomic studies of CRC to historically underrepresented populations.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-19
DOI
https://doi.org/10.3390/ijms272210442
Primary Topic
Genetic factors in colorectal cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Divergent Driver Mutation Frequencies and an Exploratory Prognostic Genomic Score in Colorectal Cancer: A Cohort Study from Kazakhstan

Ainur R. Akilzhanova, Akbota M. Aitkulova, Dos D. Sarbassov, Dauren Yerezhepov et al.
International Journal of Molecular Sciences
Genetic factors in colorectal cancer
article

Divergent Driver Mutation Frequencies and an Exploratory Prognostic Genomic Score in Colorectal Cancer: A Cohort Study from Kazakhstan

Ainur R. Akilzhanova, Akbota M. Aitkulova, Dos D. Sarbassov, Dauren Yerezhepov, Saule Rakhimova, Asset Z. Daniyarov
article en

Abstract

Colorectal cancer (CRC) exhibits substantial genomic heterogeneity across populations, yet patients from Kazakhstan remain markedly underrepresented in large-scale genomic studies. Here, we characterized the somatic mutational landscape of CRC in a cohort from Kazakhstan using targeted next-generation sequencing (NGS) and compared the observed genomic profile with data from the American Association for Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange (GENIE) database. Tumor samples from 32 patients with CRC were profiled using the TruSight Oncology 500 (TSO500) assay, and the mutation frequencies and patterns of co-occurring alterations were compared with those in a GENIE reference cohort of 770 CRC cases. The most frequently altered genes in the Kazakhstan cohort were TP53 (53%), APC (50%), and KRAS (44%). Comparative analysis identified differences in mutation frequencies between the analyzed cohorts, including a higher frequency of GNAS alterations (19%) and a lower frequency of APC alterations in the Kazakhstan cohort compared with the GENIE reference cohort. Co-occurrence analysis revealed recurrent combinations of driver alterations, including concurrent TP53 and KRAS mutations. To explore the clinical relevance of the genomic profile, a cohort-derived 11-gene cumulative mutation score was evaluated in survival analysis. A higher score was associated with shorter progression-free survival (PFS) in univariable Cox regression (HR, 1.23; 95% CI, 1.02–1.50; p = 0.034), but this association was not retained after adjustment for age, sex, and pathological stage (HR, 1.07; 95% CI, 0.84–1.36; p = 0.587). The score showed a moderate positive correlation with tumor mutational burden (TMB), which persisted after exclusion of the hypermutated microsatellite instability-high (MSI-H) case. However, the association between TMB and PFS was not retained after exclusion of this case. Bootstrap validation of the full multivariable Cox model indicated potential overfitting, with the optimism-corrected C-index decreasing from 0.732 to 0.650. These findings provide an initial molecular characterization of CRC in a cohort of patients from Kazakhstan and identify differences in selected somatic mutation frequencies compared with an international reference dataset. However, the limited sample size and differences in clinical and technical characteristics between cohorts preclude conclusions regarding population-specific genomic features. The prognostic findings remain exploratory and require validation in larger, independent cohorts. These results highlight the importance of expanding genomic studies of CRC to historically underrepresented populations.

International Journal of Molecular SciencesVol. 27(22)
Nazarbayev University (KZ)
Genetic factors in colorectal cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon